July 24, 2009 18:34 ET
OTTAWA, ONTARIO--(Marketwire - July 24, 2009) - Health Canada is warning Canadians with milk allergies not to use the unauthorized health product, Dophilus Chewable Tablets (90 tablets), labelled as "non-dairy," because they contain trace amounts of milk protein from dairy ingredients used in the production process. In this light, this product is incorrectly labelled as a non-dairy source of probiotic bacteria.
Individuals with milk allergies can experience a variety of symptoms when exposed to even small amounts of milk proteins. These symptoms include breathing difficulties which in some cases can become fatal. Health Canada is aware of one allergic adverse reaction report possibly associated with the use of Dophilus Chewable Tablets. The consumer experienced hives, vomiting, a runny nose and diarrhea. After discontinuation of the product by the consumer, the symptoms cleared.
Consumers with milk allergies should stop using this product immediately and should return it to the point of purchase. Canadians who have used this product and are concerned about their health should consult with a health care professional.
S.I.S.U. Inc., the manufacturer, has initiated a voluntary recall of Dophilus Chewable Tablets. Health Canada is taking steps to confirm that this product has been removed from the Canadian market.
Authorized health products will bear an eight-digit Drug Identification Number (DIN), a Natural Product Number (NPN), or a Homeopathic Medicine Number (DIN-HM). This authorization indicates that the products have been assessed by Health Canada for safety, effectiveness and quality.
Consumers should contact the Health Products and Food Branch Inspectorate at 1-800-267-9675 if they find the product listed in this Warning being sold in Canada.
Consumers requiring more information about this advisory can contact Health Canada's public enquiries line at (613) 957-2991, or toll free at 1-866-225-0709.
To report a suspected adverse reaction involving this health product, please contact the Canada Vigilance Program of Health Canada by one of the following methods:
Telephone: 1-866-234-2345Facsimile: 1-866-678-6789
Canada Vigilance ProgramMarketed Health Products DirectorateOttawa, Ontario, AL 0701CK1A 0K9
Media Inquiries:Health Canada613-957-2983orPublic Inquiries:613-957-29911-866-225-0709
See all RSS Newsfeeds